Junji Yamaguchi Selected Research

Junji Yamaguchi Research Topics

Disease

3	Parkinson Disease (Parkinson's Disease) 01/2021 - 03/2015
3	Starvation 01/2019 - 01/2003
2	Hypoxia (Hypoxemia) 01/2022 - 01/2003
2	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 01/2022 - 07/2017
2	Hemorrhage 08/2018 - 03/2017
2	Atrial Fibrillation 08/2018 - 08/2013
2	Thromboembolism 08/2018 - 11/2017
2	Venous Thrombosis (Deep-Vein Thrombosis) 03/2018 - 08/2013
2	Venous Thromboembolism 12/2017 - 11/2017
2	Pulmonary Embolism 11/2017 - 08/2013
2	Infections 06/2012 - 11/2009
1	Myocardial Infarction 01/2022
1	Infarction (Infarctions) 01/2022
1	Proteostasis Deficiencies 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Ectopic Junctional Tachycardia 01/2021
1	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 01/2020
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2020
1	Neuroblastoma 01/2020
1	Ventricular Tachycardia 06/2019
1	Cerebellar Diseases (Cerebellar Syndrome) 10/2018
1	Hematoma 04/2018
1	Perinatal Death 03/2018
1	Heart Failure 01/2018
1	Neoplasms (Cancer) 12/2017
1	Antithrombin III Deficiency 11/2017
1	Shock 09/2015
1	Ventricular Fibrillation 09/2015
1	Eosinophilia 09/2014
1	Diffuse Esophageal Spasm (Esophageal Spasm) 09/2014
1	Hypochromic Anemia (Chlorosis) 02/2014
1	Hypersensitivity (Allergy) 08/2013
1	Dehydration (Water Stress) 11/2009

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2009
3	AnticoagulantsIBA 08/2018 - 11/2017
2	Cathepsin DIBA 01/2022 - 07/2017
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2020
2	SynucleinsIBA 01/2022 - 01/2021
2	SugarsIBA 01/2019 - 01/2003
2	Warfarin (Coumadin)FDA LinkGeneric 08/2018 - 08/2013
2	RivaroxabanIBA 11/2017 - 08/2013
2	Messenger RNA (mRNA)IBA 11/2009 - 12/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	LigandsIBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022
1	Durapatite (Hydroxylapatite)IBA 01/2022
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2022
1	tau Proteins (tau Protein)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	AntioxidantsIBA 01/2020
1	Verapamil (Calan)FDA LinkGeneric 06/2019
1	UbiquitinIBA 01/2019
1	Ligases (Synthetase)IBA 01/2019
1	edoxabanIBA 12/2017
1	Antithrombin IIIIBA 11/2017
1	Heparin (Liquaemin)FDA LinkGeneric 11/2017
1	DNA (Deoxyribonucleic Acid)IBA 03/2015
1	NucleotidesIBA 03/2015
1	Immunoglobulin E (IgE)IBA 09/2014
1	SteroidsIBA 09/2014
1	Anthocyanins (Anthocyanin)IBA 02/2014
1	ChitinIBA 06/2012
1	ElementsIBA 11/2009
1	ethyleneIBA 11/2009
1	Carrier Proteins (Binding Protein)IBA 11/2009
1	NitrogenIBA 12/2003
1	Ammonium CompoundsIBA 12/2003
1	alpha-AmylasesIBA 01/2003
1	EnzymesIBA 01/2003
1	GibberellinsIBA 01/2003
1	Starch (Cornstarch)IBA 01/2003

Therapy/Procedure

6	Therapeutics 01/2021 - 09/2014
1	Ligation 01/2022
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2020
1	Catheter Ablation 08/2018
1	Pericardiectomy 04/2018
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2018
1	Vena Cava Filters (Inferior Vena Cava Filter) 03/2018
1	Contraindications 03/2017
1	Percutaneous Coronary Intervention 09/2015